Skip to content

Insider · CIK 0001922252

Michael Lee Reed

director

Files at NUTX (Nutex Health, Inc.). First filing -, latest -.

In brief

Michael Lee Reed files SEC Form 4 as director at NUTX (Nutex Health, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Michael Lee Reed has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jul 31, 2026NUTX
Nutex Health, Inc.
MOption exercise
Common Stockindirect: See note (2)
+603$0.00$0670Aug 3, 2026
Apr 23, 2026NUTX
Nutex Health, Inc.
AGrant or award
Restricted Stock Units (RSUs)derivative
+823$0.00$01,426Apr 24, 2026
Jul 14, 2025NUTX
Nutex Health, Inc.
AGrant or award
Restricted Stock Units (RSUs)derivative
+603$0.00$0603Feb 9, 2026

Questions about Michael Lee Reed

Answered from the filings on this page, as of the latest one.

Is Michael Lee Reed buying or selling?

Michael Lee Reed has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Michael Lee Reed's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Lee Reed has 0.

Where does Michael Lee Reed file Form 4?

Michael Lee Reed has filed Form 4 at NUTX (Nutex Health, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Michael Lee Reed: insider trades and track record | InsiderTell